Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting

Researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia’s MammaPrint®, BluePrint™, and ColoPrint™ at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. The study results underpin the broad predictive and prognostic power of MammaPrint and highlight prospective and independently validated data on ColoPrint. Visitors can meet the Agendia team in booth #18018.

Source: Agendia